ACSS2 and non-small cell lung carcinoma: In the current study, in all the NSCLC cells studied, ACSS2 expression was higher than that of ACSS1, both in control and orlistat-treated cells, demonstrating the high dependency of these cell lines on de novo FA for their metabolic needs.